This activity seeks to review innovative clinical trials in the treatment of head and neck cancers from a radiation, surgical and systemic therapy perspective. These trials have novel translational components that may spearhead the next generation of novel clinical trials in these diseases.

This session will review the latest science in the field of head and neck cancer.

We are in an era of abundant technological innovation. Numerous emerging tools may allow clinicians to evaluate the status of cancer and make clinical decisions faster and less invasively.

Dr. Carmen Guerra presents on the persistent racial and ethnic disparities that exist in patient access to clinical trials in head and neck oncology.

It is imperative that our HNSCC medical care team across specialties professional remain current in the state-of-the-art techniques (Knowledge).

This session reviews head and neck cancers from a patient perspective.

This session will review the key takeaways from the 2023 Multidisciplinary Thoracic Cancers Symposium.

Prognosis, therapeutic choices, end of life care are three key themes for patients with lung cancer.

Advancements in the diagnosis and treatment of thoracic cancers have improved survival rates, making survivorship issues such as fertility and sexual wellness a priority.

The management of stage III NSCLC is controversial and rapidly evolving, to the point that practitioners have difficulty processing and understanding the fast moving changes in the standard of care and communications among multidisciplinary teams is challenging given the uneven knowledge levels.